Page last updated: 2024-10-27

fleroxacin and Liver Cirrhosis

fleroxacin has been researched along with Liver Cirrhosis in 1 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"In this open-label study, the disposition of fleroxacin in liver disease in 12 healthy male volunteers, 6 male cirrhotics without ascites (group A), and 6 male cirrhotics with ascites (group B) was evaluated."7.68Fleroxacin pharmacokinetics in patients with liver cirrhosis. ( Blouin, RA; Foster, TS; Hamelin, BA; John, WJ; Smith, DA; Welker, HA, 1992)
"In this open-label study, the disposition of fleroxacin in liver disease in 12 healthy male volunteers, 6 male cirrhotics without ascites (group A), and 6 male cirrhotics with ascites (group B) was evaluated."3.68Fleroxacin pharmacokinetics in patients with liver cirrhosis. ( Blouin, RA; Foster, TS; Hamelin, BA; John, WJ; Smith, DA; Welker, HA, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blouin, RA1
Hamelin, BA1
Smith, DA1
Foster, TS1
John, WJ1
Welker, HA1

Other Studies

1 other study available for fleroxacin and Liver Cirrhosis

ArticleYear
Fleroxacin pharmacokinetics in patients with liver cirrhosis.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antipyrine; Ascites; Fleroxacin; Humans; Infusions, Intravenous;

1992